Received Jan 8, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | YN2X2 | IM / LL |
Patient came to office for well check and after checking registry, pt was due for Dtap and Hep A. Discussed with parent and parent agreed to give Dtap today. Patient was given Kinrix by mistake. I called GSK manufacturer to see what recommendations and follow up was needed. They stated the specialist was not available but would e-mail me the information needed. Case number for GSK. I called patients mother to notify her about the Kinrix being given ratther than the plain Dtap and she stated understanding and will call back with any concerns or questions. I will call mother back after receiving further information from GSK as indicated. Safety Report placed. Mother stated no signs or symptoms of adverse reaction observed.
None
None
None
None Known
NA